Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH3 or 2-CH3. Issue 2 (15th January 2017)
- Record Type:
- Journal Article
- Title:
- Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH3 or 2-CH3. Issue 2 (15th January 2017)
- Main Title:
- Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH3 or 2-CH3
- Authors:
- Gunia-Krzyżak, Agnieszka
Żelaszczyk, Dorota
Rapacz, Anna
Żesławska, Ewa
Waszkielewicz, Anna M.
Pańczyk, Katarzyna
Słoczyńska, Karolina
Pękala, Elżbieta
Nitek, Wojciech
Filipek, Barbara
Marona, Henryk - Abstract:
- Graphical abstract: Highlights: ( E )- N- cinnamoyl derivatives of aminoalkanols were tested in rodents. Maximal electroshock, subcutaneous pentylenetetrazole and 6-Hz tests were performed. Anticonvulsant activity was enhanced by p -Cl and o -CH3 substitution in phenyl ring. Benzodiazepine receptors and serotonergic receptors were possible molecular targets. Tested compounds were stable in rat liver microsomes model of biotransformation. Abstract: A series of twenty two ( E )- N- cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH3 or 2-CH3 was designed, synthesized and evaluated for anticonvulsant activity in rodent models of seizures: maximal electroshock (MES) test, subcutaneous pentylenetetrazole (scPTZ) test, and 6-Hz test. There were identified three most active compounds: S -(2 E )- N -(1-hydroxypropan-2-yl)-3-(2-methylphenyl)prop-2-enamide (5 ) (ED50 MES = 42.56, ED50 scPTZ = 58.38, ED50 6-Hz 44 mA = 42.27 mg/kg tested in mice after intraperitoneal ( i.p .) administration); R, S -(2 E )-3-(4-chlorophenyl)- N -(1-hydroxybutan-2-yl)prop-2-enamide (6 ) (ED50 MES = 53.76, ED50 scPTZ = 90.31, ED50 6-Hz 44 mA = 92.86 mg/kg mice, i.p .); and R, S -(2 E )-3-(4-chlorophenyl)- N -(2-hydroxypropyl)prop-2-enamide (11 ) (ED50 MES = 55.58, ED50 scPTZ = 102.15, ED50 6-Hz 44 mA = 51.27 mg/kg mice, i.p .). Their structures and configurations were confirmed by crystal X-ray diffraction method. The structure-activity studies among the tested series showedGraphical abstract: Highlights: ( E )- N- cinnamoyl derivatives of aminoalkanols were tested in rodents. Maximal electroshock, subcutaneous pentylenetetrazole and 6-Hz tests were performed. Anticonvulsant activity was enhanced by p -Cl and o -CH3 substitution in phenyl ring. Benzodiazepine receptors and serotonergic receptors were possible molecular targets. Tested compounds were stable in rat liver microsomes model of biotransformation. Abstract: A series of twenty two ( E )- N- cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH3 or 2-CH3 was designed, synthesized and evaluated for anticonvulsant activity in rodent models of seizures: maximal electroshock (MES) test, subcutaneous pentylenetetrazole (scPTZ) test, and 6-Hz test. There were identified three most active compounds: S -(2 E )- N -(1-hydroxypropan-2-yl)-3-(2-methylphenyl)prop-2-enamide (5 ) (ED50 MES = 42.56, ED50 scPTZ = 58.38, ED50 6-Hz 44 mA = 42.27 mg/kg tested in mice after intraperitoneal ( i.p .) administration); R, S -(2 E )-3-(4-chlorophenyl)- N -(1-hydroxybutan-2-yl)prop-2-enamide (6 ) (ED50 MES = 53.76, ED50 scPTZ = 90.31, ED50 6-Hz 44 mA = 92.86 mg/kg mice, i.p .); and R, S -(2 E )-3-(4-chlorophenyl)- N -(2-hydroxypropyl)prop-2-enamide (11 ) (ED50 MES = 55.58, ED50 scPTZ = 102.15, ED50 6-Hz 44 mA = 51.27 mg/kg mice, i.p .). Their structures and configurations were confirmed by crystal X-ray diffraction method. The structure-activity studies among the tested series showed that chlorine atom in position para or methyl group in position ortho of phenyl ring were beneficial for anticonvulsant activity. Methyl group in position para of phenyl ring decreased anticonvulsant activity in reported series of cinnamamide derivatives. … (more)
- Is Part Of:
- Bioorganic & medicinal chemistry. Volume 25:Issue 2(2017)
- Journal:
- Bioorganic & medicinal chemistry
- Issue:
- Volume 25:Issue 2(2017)
- Issue Display:
- Volume 25, Issue 2 (2017)
- Year:
- 2017
- Volume:
- 25
- Issue:
- 2
- Issue Sort Value:
- 2017-0025-0002-0000
- Page Start:
- 471
- Page End:
- 482
- Publication Date:
- 2017-01-15
- Subjects:
- Anticonvulsant -- Cinnamamide -- Crystal structure -- MES -- Pharmacophore -- scPTZ -- 6-Hz
LHOCIRAREVNAKF-AEZGRPFRSA-N -- PRRQIMZFWXXIRY-VMPITWQZSA-N -- SVLVGTSFQFZIBO-QPJJXVBHSA-N
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Chemistry, Clinical -- Periodicals
Chemistry, Organic -- Periodicals
Chimie bio-organique -- Périodiques
Chimie pharmaceutique -- Périodiques
615.19 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09680896 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmc.2016.11.014 ↗
- Languages:
- English
- ISSNs:
- 0968-0896
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.325000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 1091.xml